QT 5, Inc. Names Edna T. Barris as Vice President of Sales
WESTLAKE VILLAGE, Calif., April 28, 2004 -- QT 5, Inc. , manufacturer, distributor and marketer of biomedical products, has named Edna T. Barris as Vice President of Sales for all Diagnostic Products. Edna joins QT 5, Inc. with 30 years of Biomedical experience, focused on the sales and introduction of rapid diagnostic products for the last 22 years.
With a B.S. degree in Biological Science and Animal Science from Kansas State University, and graduate studies in their School of Veterinary Medicine, Edna began her career in research at Lederle Laboratories, where she is published in numerous fields.
Prior to joining QT 5, Inc., Ms. Barris was a significant part of the sales, sales training, and sales specialists' team for over a decade with Monoclonal Antibodies, Inc., later to merge with Quidel Corporation. She was instrumental in bringing rapid diagnostic testing into the hospital and POL marketplace with the first sandwich assay tests for pregnancy, ovulation, and infectious disease.
"We are excited to have her on board," said Steven H. Reder, QT 5, Inc. president. "Edna is very well respected in the medical diagnostic fields and has a very impressive group of existing relationships that have already proven invaluable."
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: www.qt5inc.com
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
CONTACT: QT 5, Inc.
Steve Reder, President
(818) 338-1510
sreder@qt5inc.com
&a=A0BM03&b=0&banner_ref=HASH(0x9e265bc)&zeitraum=8&ind_volume=ON&zoom.x=0&zeitbis=&bname=&bis=1083861439.80959&cookies=HASH(0x9ed0d40)&req_host=ARRAY(0x9ea7ac8)&zeitvon=0&von=0)
